MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 8011-8020 Newer>
The Motley Fool
October 31, 2011
Brian Orelli
Spectrum Looking More Investable Spectrum's problem is that it's hard to value the unknown. mark for My Articles 322 similar articles
The Motley Fool
October 31, 2011
Eric Bleeker
Where Amgen Is Finding Its Growth Five years ago, Amgen collected 83% of its sales from the United States. mark for My Articles 284 similar articles
The Motley Fool
October 31, 2011
Brian Orelli
When Getting Beat Down Is No Big Deal Merck is getting smacked down by Vertex Pharmaceuticals in the hepatitis C market, but it has the bulk to take a beating. mark for My Articles 484 similar articles
CIO
October 28, 2011
Kim S. Nash
Challenging Times for Pfizer As drug patents expire, the pharmaceutical giant is investing in technology and emerging markets while cutting back on R&D and labor. mark for My Articles 315 similar articles
The Motley Fool
October 29, 2011
Frank Vinluan
IBM's Watson Offers a Glimpse Into Health IT's Future The supercomputer will help doctors, not replace them, as one IBM official sees it. mark for My Articles 120 similar articles
The Motley Fool
October 28, 2011
Dawn Kawamoto
Supplement Makers Choke With Vitamin E Tied to Prostate Cancer A study gives vitamin supplement makers and their investors a potentially bitter pill to swallow. mark for My Articles 166 similar articles
The Motley Fool
October 28, 2011
Brian Orelli
Invest in Biotechs Going After Unmet Needs What a quarter it was for Vertex Pharmaceuticals: $420 million in net sales of its new hepatitis C drug. mark for My Articles 125 similar articles
The Motley Fool
October 27, 2011
Eric Bleeker
Here's Where Agilent's Finding Its Growth Four years ago, Agilent produced 34% of its sales within the United States. mark for My Articles 30 similar articles
The Motley Fool
October 27, 2011
Brian Orelli
DEFINE First, CONFIRM Second, See Shares Rise 60% Third Biogen CONFIRMs it has a new blockbuster drug and shares jump. mark for My Articles 204 similar articles
The Motley Fool
October 27, 2011
Eric Bleeker
Here's Where Pfizer's Finding Its Growth Let's examine where Pfizer's sales and earnings come from and how its sales abroad have changed over time. mark for My Articles 368 similar articles
<Older 8011-8020 Newer>    Return to current articles.